Healthcare Trust of America, Inc. (NYSE:HTA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday.

According to Zacks, “Healthcare Trust of America, Inc. is a self-administered real estate investment trust. The Company primarily focuses on medical office buildings, healthcare-related facilities and quality commercial office properties. It also invests to a limited extent in other real estate-related assets. Its portfolio is positioned in metropolitan markets such as Atlanta, GA, Phoenix, AZ, Indianapolis, IN, Greenville, SC, Pittsburgh, PA, Albany, NY, Boston, MA and both Dallas and Houston, TX. Healthcare Trust of America, Inc. is headquartered in Scottsdale, Arizona. “

A number of other equities analysts have also recently commented on HTA. BidaskClub cut shares of Healthcare Trust of America from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. TheStreet cut shares of Healthcare Trust of America from a “b-” rating to a “c” rating in a research note on Monday, July 31st. BMO Capital Markets raised shares of Healthcare Trust of America from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $33.00 to $35.00 in a research note on Tuesday, June 20th. They noted that the move was a valuation call. Wells Fargo & Company reaffirmed an “outperform” rating and set a $35.00 price target (up from $33.50) on shares of Healthcare Trust of America in a research note on Friday, June 16th. Finally, Stifel Nicolaus dropped their price target on shares of Healthcare Trust of America from $36.00 to $34.00 and set a “buy” rating for the company in a research note on Wednesday, July 12th. Two analysts have rated the stock with a sell rating, eight have issued a buy rating and two have given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $34.50.

Shares of Healthcare Trust of America (NYSE HTA) traded down 0.46% during trading on Tuesday, hitting $30.05. 1,210,543 shares of the stock traded hands. The stock has a market cap of $6.03 billion, a PE ratio of 147.30 and a beta of 0.32. The firm’s 50-day moving average price is $30.27 and its 200-day moving average price is $30.94. Healthcare Trust of America has a 12 month low of $26.34 and a 12 month high of $34.64.

Healthcare Trust of America (NYSE:HTA) last issued its quarterly earnings data on Monday, July 31st. The real estate investment trust reported $0.39 EPS for the quarter, hitting analysts’ consensus estimates of $0.39. Healthcare Trust of America had a net margin of 6.07% and a return on equity of 1.42%. The business had revenue of $139.90 million during the quarter, compared to analysts’ expectations of $133.69 million. During the same period last year, the company posted $0.38 EPS. The business’s revenue was up 23.6% on a year-over-year basis. Analysts anticipate that Healthcare Trust of America will post $0.23 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Zacks Investment Research Downgrades Healthcare Trust of America, Inc. (HTA) to Sell” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/15/zacks-investment-research-downgrades-healthcare-trust-of-america-inc-hta-to-sell.html.

In related news, CEO Scott D. Peters sold 55,240 shares of Healthcare Trust of America stock in a transaction dated Tuesday, June 27th. The shares were sold at an average price of $32.06, for a total transaction of $1,770,994.40. Following the completion of the sale, the chief executive officer now owns 405,092 shares in the company, valued at approximately $12,987,249.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.50% of the stock is currently owned by insiders.

A number of large investors have recently made changes to their positions in HTA. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its stake in shares of Healthcare Trust of America by 2.3% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 22,412 shares of the real estate investment trust’s stock worth $705,000 after buying an additional 512 shares during the last quarter. Brookstone Capital Management bought a new stake in shares of Healthcare Trust of America during the first quarter worth $209,000. Canada Pension Plan Investment Board bought a new stake in shares of Healthcare Trust of America during the first quarter worth $7,865,000. Russell Investments Group Ltd. raised its stake in shares of Healthcare Trust of America by 39.3% in the first quarter. Russell Investments Group Ltd. now owns 585,942 shares of the real estate investment trust’s stock worth $18,433,000 after buying an additional 165,373 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D bought a new stake in shares of Healthcare Trust of America during the first quarter worth $3,146,000. Institutional investors own 70.89% of the company’s stock.

Healthcare Trust of America Company Profile

Healthcare Trust of America, Inc is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations.

Get a free copy of the Zacks research report on Healthcare Trust of America (HTA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Healthcare Trust of America (NYSE:HTA)

Receive News & Ratings for Healthcare Trust of America Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Trust of America Inc. and related companies with MarketBeat.com's FREE daily email newsletter.